The first aspartic acid of the DQxD motif for human UDP-glucuronosyltransferase 1A10 interacts with UDP-glucuronic acid during catalysis

被引:14
|
作者
Xiong, Yan [1 ]
Patana, Anne-Sisko [2 ]
Miley, Michael J. [4 ]
Zielinska, Agnieszka K. [1 ]
Bratton, Stacie M. [1 ]
Miller, Grover P. [1 ]
Goldman, Adrian [2 ,3 ]
Finel, Moshe [8 ]
Redinbo, Matt R. [5 ,6 ,7 ]
Radominska-Pandya, Anna [1 ]
机构
[1] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA
[2] Univ Helsinki, Inst Biotechnol, Helsinki, Finland
[3] Univ Helsinki, Ctr Neurosci, Helsinki, Finland
[4] Univ N Carolina, Dept Chem, Chapel Hill, NC USA
[5] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC USA
[6] Univ N Carolina, Program Mol Biol & Biotechnol, Chapel Hill, NC 27599 USA
[7] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA
[8] Univ Helsinki, Fac Pharm, Drug Discovery & Dev Technol Ctr, Helsinki, Finland
关键词
D O I
10.1124/dmd.107.016469
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
All UDP-glucuronosyltransferase enzymes (UGTs) share a common cofactor, UDP-glucuronic acid (UDP-GlcUA). The binding site for UDP-GlcUA is localized to the C-terminal domain of UGTs on the basis of amino acid sequence homology analysis and crystal structures of glycosyltransferases, including the C-terminal domain of human UGT2B7. We hypothesized that the (393)DQMD-NAK(399) region of human UGT1A10 interacts with the glucuronic acid moiety of UDP-GlcUA. Using site-directed mutagenesis and enzymatic analysis, we demonstrated that the D393A mutation abolished the glucuronidation activity of UGT1A10 toward all substrates. The effects of the alanine mutation at Q(394), D-396, and K-399 on glucuronidation activities were substrate-dependent. Previously, we examined the importance of these residues in UGT2B7. Although D-393 (D-398 in UGT2B7) is similarly critical for UDP-GlcUA binding in both enzymes, the effects of Q(394) (Q(399) in UGT2B7) to Ala mutation on activity were significant but different between UGT1A10 and UGT2B7. A model of the UDP-GlcUA binding site suggests that the contribution of other residues to cosubstrate binding may explain these differences between UGT1A10 and UGT2B7. We thus postulate that D-393 is critical for the binding of glucuronic acid and that proximal residues, e. g., Q(394) (Q(399) in UGT2B7), play a subtle role in cosubstrate binding in UGT1A10 and UGT2B7. Hence, this study provides important new information needed for the identification and understanding of the binding sites of UGTs, a major step forward in elucidating their molecular mechanism.
引用
收藏
页码:517 / 522
页数:6
相关论文
共 50 条
  • [31] Identification of the human UDP-glucuronosyltransferase responsible for the glucuronidation of niflumic acid in the liver
    Mano, Yuji
    Usui, Takashi
    Kamimura, Hidetaka
    DRUG METABOLISM REVIEWS, 2006, 38 : 252 - 253
  • [32] ISOLATION AND CHARACTERIZATION OF HYODEOXYCHOLIC ACID UDP-GLUCURONOSYLTRANSFERASE FROM HUMAN LIVER
    MATERN, H
    LAPPAS, N
    MATERN, S
    HEPATOLOGY, 1991, 14 (04) : A257 - A257
  • [33] Identification of Human UDP-Glucuronosyltransferase Isoforms Responsible for the Glucuronidation of Glycyrrhetinic Acid
    Lu, Yang
    Zhu, Jing
    Chen, Xijing
    Li, Ning
    Fu, Feifei
    He, Jiake
    Wang, Guangji
    Zhang, Lingli
    Zheng, Yi
    Qiu, Zhixia
    Yu, Xue
    Han, Deen
    Wu, Lei
    DRUG METABOLISM AND PHARMACOKINETICS, 2009, 24 (06) : 523 - 528
  • [34] Interplay of structural preorganization and conformational sampling in UDP-glucuronic acid 4-epimerase catalysis
    Rapp, Christian
    Borg, Annika
    Nidetzky, Bernd
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [35] Identification of human UDP-glucuronosyltransferase responsible for the glucuronidation of niflumic acid in human liver
    Mano, Yuji
    Usui, Takashi
    Kamimura, Hidetaka
    PHARMACEUTICAL RESEARCH, 2006, 23 (07) : 1502 - 1508
  • [36] Identification of Human UDP-Glucuronosyltransferase Responsible for the Glucuronidation of Niflumic Acid in Human Liver
    Yuji Mano
    Takashi Usui
    Hidetaka Kamimura
    Pharmaceutical Research, 2006, 23 : 1502 - 1508
  • [37] HUMAN UDP-GLUCURONOSYLTRANSFERASE (UGT)1A3 CONJUGATES NORURSODEOXYCHOLIC ACID IN THE LIVER
    Trottier, Jocelyn
    El Husseini, Diala
    Perreault, Martin
    Paquet, Sophie
    Caron, Patrick
    Trauner, Michael H.
    Barbier, Olivier
    HEPATOLOGY, 2009, 50 (04) : 1017A - 1017A
  • [38] Inhibition of Intestinal UDP-Glucuronosyltransferase (UGT) 1A7 and 1A10 by Ovarian Cancer Treatment Drug
    Li, Hui
    Wang, Hui
    Yu, Xiaoqian
    Du, Xiulan
    LATIN AMERICAN JOURNAL OF PHARMACY, 2017, 36 (06): : 1227 - 1230
  • [39] HEPATIC UDP-GLUCOSE AND UDP-GLUCURONIC ACID SYNTHESIS RATES IN RATS DURING A REDUCED ENERGY-STATE
    DILLS, RL
    HOWELL, SR
    KLAASSEN, CD
    DRUG METABOLISM AND DISPOSITION, 1987, 15 (03) : 281 - 288
  • [40] REGULATORY MECHANISMS OF UDP-GLUCURONIC ACID BIOSYNTHESIS IN CULTURED HUMAN-SKIN FIBROBLASTS
    CASTELLANI, AA
    DELUCA, G
    RINDI, S
    SALVINI, R
    TIRA, ME
    ITALIAN JOURNAL OF BIOCHEMISTRY, 1986, 35 (05): : 296 - 303